what to deal does in a round about way, and its a long large circle, is buy the rights, licence for 78 % in new company for $22million ish. a nothingness for them in the land of big pharma or even little ones.
and as other pose what about other partnerhips apparently stlll operating, pls explain, and that should have been in the announcement
anyway keeps , staff employed, and the new director of the other company can play similar games.
Ann: Change in Director's Interest Notice - R Basser, page-7
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.20M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $22.86K | 218.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 348003 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 54598 | 6 |
View Market Depth
| Last trade - 16.10pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
10.0¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 10.5¢ | 10.5¢ | 10.0¢ | 171817 | ||
| Last updated 15.35pm 05/06/2024 ? | |||||
| SPL (ASX) Chart |